학술논문
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040
Document Type
Article
Author
Source
In Annals of Oncology April 2024 35(4):381-391
Subject
Language
ISSN
0923-7534